Zobrazeno 1 - 10
of 39
pro vyhledávání: '"M J, Gil Sanz"'
Autor:
A, Borque-Fernando, R, Espílez, D, Miramar, D, Corbatón, A, Rodríguez, E, Castro, J, Mateo, L, Rello, A, Méndez, M J, Gil Sanz
Publikováno v:
Actas urologicas espanolas. 45(1)
Prostate cancer plays an undeniably prominent role in public health in our days and health systems. Its epidemiological impact is quantitatively very close to that of other tumors such as colon cancer and breast cancer, in which genetic counseling is
Autor:
M Sanz, Del Pozo, Cristina, Redondo, F Romero, Fernández, M J Gil, Sanz, J Subirá, Ríos, A, Borque-Fernando
Publikováno v:
Journal of cancer education : the official journal of the American Association for Cancer Education. 37(1)
This project aims to complement and homogenise the teaching of indications and technique of digital rectal examination (DRE) through the use of simulators, and subsequently analysed the level of satisfaction with the training and skills acquired. The
Autor:
Á, Borque-Fernando, L M, Esteban-Escaño, J, Rubio-Briones, A C, Lou-Mercadé, R, García-Ruiz, A, Tejero-Sánchez, M V, Muñoz-Rivero, T, Cabañuz-Plo, J, Alfaro-Torres, I M, Marquina-Ibáñez, S, Hakim-Alonso, E, Mejía-Urbáez, J, Gil-Fabra, P, Gil-Martínez, R, Ávarez-Alegret, G, Sanz, M J, Gil-Sanz
Publikováno v:
Actas urologicas espanolas. 40(3)
To prevent the overdiagnosis and overtreatment of prostate cancer (PC), therapeutic strategies have been established such as active surveillance and focal therapy, as well as methods for clarifying the diagnosis of high-grade prostate cancer (HGPC) (
Autor:
J, Rioja Zuazu, E, Bandrés Elizalde, D, Rosell Costa, A, Rincón Mayans, J, Zudaire Bergera, M J, Gil Sanz, L A, Rioja Sanz, J, García Foncillas, J M, Berián Polo
Publikováno v:
Actas urologicas espanolas. 31(10)
Steroid and Xenobiotic Receptor (SXR) has demonstrated its activation by numerous drugs, including cytochrome P450 potent inducers like rifampicina or cotrimazol. The role of SXR is well known, and lies regulating in a positive manner cytochrome P450
Publikováno v:
Actas urologicas espanolas. 31(8)
Owing to the different results from the series that evaluate the behavior of the bladder cancer according to the age at the moment of the diagnosis, our objective is based on valuing the characteristics and behaviour according to age of appearance.A
Autor:
E, Mallén Mateo, P, Gil Martínez, M J, Gil Sanz, C, Sancho Serrano, D, Pascual Regueriro, L A, Rioja Sanz
Publikováno v:
Actas urologicas espanolas. 30(8)
To evaluate the data of progression and survival in 43 patients who underwent cystectomy with stage pT0 according to classification TNM-2002.between 1988 and 2003 in our center had realized 420 cystectomies, 43 patients (10.2%) had not tumor in the c
Autor:
E, Mallén Mateo, C, Sancho Serrano, D, Pascual Regueiro, A, García de Jalón Martínez, M J, Gil Sanz, A, Gonzalvo Ibarra, L A, Rioja Sanz
Publikováno v:
Actas urologicas espanolas. 29(3)
Primitive neuroectodermal tumor is an extraordinarily rare primary tumor in the kidney and can be mistaken for a variety of other round cell tumors. It is important to recognize each of these entities, because each carries unique therapeutic and prog
Autor:
E, Mallén Mateo, M J, Gil Sanz, C, Sancho Serrano, D, Pascual Regueiro, A, García de Jalón Martínez, L A, Rioja Sanz
Publikováno v:
Actas urologicas espanolas. 28(6)
After renal parenchymal sparing surgery, with the use of surgical gelatin sponge, residual defects may persist on imaging studies at the sites of resection. These "pseudotumors" may lead to confusion as to whether a lesion was removed or has recurred
Autor:
M J, Gil Sanz
Publikováno v:
Actas urologicas espanolas. 28(2)
Autor:
D, Pascual Regueiro, E, Mallén Mateo, M A, Trívez Boned, M A, García García, M J, Gil Sanz, L A, Rioja Sanz
Publikováno v:
Actas urologicas espanolas. 27(8)
We present a case of an urothelial tumor pelvic recurrence, five months after radical cystoprostatectomy. No fat infiltration was demonstrated in the pathological study of the transurethral resection pieces. The treatment was a radical cystoprostatec